Clinical Trials Browser

Breast Neoplasms

Lymphadenopathy, Breast Cancer Lymphedema, COVID-19, Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Ovarian Neoplasms

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Invasive Breast Cancer

Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

Breast Neoplasms

Breast Cancer Female

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Sleep Initiation and Maintenance Disorders

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Cancer Female

Breast Neoplasms

Breast Cancer Female

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Osteoporosis

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Pain, Arthralgia

Breast Neoplasms, Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Cancer Screening

Breast Neoplasms

Breast Neoplasms

Clinical Trials

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

LymphVAX

REaCT-Algorith

TARGIT_BQR

e-DomSanté

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole

Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)

Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

Promoting Informed Choice for Breast Cancer Screening

NEAR

Assessing the Time Demands of Cancer

CINNAMOME

BEAUTY

PRIORITY

A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

EXERT-BC

Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle

A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients

PERSONAL - Sleep In Breast Cancer

INTRA-OBS

ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

Brevera™ Breast Biopsy System Data Collection Study

RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Palbociclib in Real World Practice

Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy

SIMBA

A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.

Evaluation of BIS for Quantification of Lymphedema

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

MAP3BSS

B-SUPER

A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark

Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC

Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.

Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer

Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer

Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study

Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing

HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes

Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions

Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy

ROIS